Fennec Pharmaceuticals Inc [FENC] stock prices are down -0.50% to $6.01 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The FENC shares have gain 29.53% over the last week, with a monthly amount glided 25.47%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Fennec Pharmaceuticals Inc [NASDAQ: FENC] stock has seen the most recent analyst activity on November 22, 2022, when Cantor Fitzgerald upgraded its rating to a Overweight and also boosted its price target to $12 from $9. Previously, CapitalOne started tracking the stock with Overweight rating on September 07, 2022, and set its price target to $11. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $18 on June 05, 2020. Goldman initiated its recommendation with a Buy.
The stock price of Fennec Pharmaceuticals Inc [FENC] has been fluctuating between $3.96 and $11.92 over the past year. Currently, Wall Street analysts expect the stock to reach $15.75 within the next 12 months. Fennec Pharmaceuticals Inc [NASDAQ: FENC] shares were valued at $6.01 at the most recent close of the market. An investor can expect a potential return of 162.06% based on the average FENC price forecast.
Analyzing the FENC fundamentals
The Fennec Pharmaceuticals Inc [NASDAQ:FENC] reported sales of 49.35M for trailing twelve months, representing a surge of 7.05%. Gross Profit Margin for this corporation currently stands at 0.94% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at -0.03%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is 0.32 and Total Capital is 0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -6.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.82 points at the first support level, and at 5.64 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.37, and for the 2nd resistance point, it is at 6.73.
Ratios To Look Out For
It’s worth pointing out that Fennec Pharmaceuticals Inc [NASDAQ:FENC]’s Current Ratio is 7.80. On the other hand, the Quick Ratio is 7.64, and the Cash Ratio is 5.42. Considering the valuation of this stock, the price to sales ratio is 3.34.
Transactions by insiders
Recent insider trading involved Raykov Rosty, Director, that happened on Nov 04 ’24 when 2431.0 shares were sold. Director, ROSTISLAV RAYKOV completed a deal on Nov 04 ’24 to buy 2431.0 shares. Meanwhile, Director RALLIS CHRIS A sold 1406.0 shares on Oct 08 ’24.
